Short QT syndrome in pediatrics

Area of Science:

• Cardiology
• Genetics
• Pediatrics

Background:

• Short QT syndrome (SQTS) is a rare, malignant cardiac channelopathy.
• It presents with ventricular tachyarrhythmias, syncope, and sudden cardiac death, particularly in the pediatric population.
• Current diagnostic criteria involve a QTc interval below 340 ms.

Purpose of the Study:

• To review the clinical hallmarks of Short QT syndrome.
• To focus on advancements in diagnosis, risk stratification, and management in pediatric patients.
• To highlight the genetic basis and current therapeutic strategies for SQTS.

Main Methods:

• Literature review of clinical, genetic, and molecular advances in Short QT syndrome.
• Analysis of diagnostic criteria and risk stratification tools.
• Evaluation of current preventive and therapeutic measures.

Main Results:

• Six genes are associated with SQTS, explaining approximately 60% of diagnosed families.
• Advances in understanding pathophysiological mechanisms have improved diagnosis and risk assessment.
• Automatic implantable cardiac defibrillators remain the most effective preventive measure.

Conclusions:

• Short QT syndrome is a significant cause of sudden cardiac death in children.
• Continued research into genetic and molecular mechanisms is crucial for improved patient outcomes.
• A multidisciplinary approach integrating genetic testing, risk stratification, and device therapy is essential for managing SQTS.